CAS: 68475-42-3 - Anagrelide
Formula:C10H7Cl2N3O
InChI:InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)
InChI key:InChIKey=OTBXOEAOVRKTNQ-UHFFFAOYSA-N
SMILES:O=C1N=C2NC3=CC=C(Cl)C(Cl)=C3CN2C1
- Synonyms:
- 11-6-1
- 6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one
- 6,7-Dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one
- 68475-42-3
- Bl 4162A
- Xagrid
- imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro-
- imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-5,10-dihydro-
6,7-dichloro-5,10-dihydro-3H-imidazo[2,1-b]quinazolin-2-one
CAS:68475-42-3
Formula:
C10H7Cl2N3O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
256.0881
Ref: IN-DA00IBU8
1mg | 53.00 € | ||
5mg | 95.00 € | ||
10mg | 137.00 € | ||
25mg | 192.00 € |
Estimated delivery in United States, on Friday 15 Nov 2024
Ref: 7W-GP3089
Undefined size | To inquire |
Estimated delivery in United States, on Monday 18 Nov 2024
Anagrelide-13C3
CAS:68475-42-3
Formula:
C713C3H7Cl2N3O
Color and Shape:
White To Off-White Solid
Molecular weight:
259.06
Ref: 4Z-A-10301
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 18 Nov 2024
Anagrelide
CAS:68475-42-3
Anagrelide (Xagrid) is a Platelet-reducing Agent.
Formula:
C10H7Cl2N3O
Purity:
100%
Color and Shape:
Solid
Molecular weight:
256.09
- Inhibitors
- Metabolism
- PDE
- Antineoplastic agents
- See more categories
- Anagrelide and Impurities
Ref: TM-T0160
1mg | 72.00 € | ||
5mg | 156.00 € | ||
10mg | 211.00 € | ||
25mg | 328.00 € | ||
50mg | 503.00 € | ||
1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Friday 22 Nov 2024
Anagrelide
CAS:68475-42-3
Anagrelide is a molecule that inhibits the JAK2 kinase and has been shown to inhibit …
Formula:
C10H7Cl2N3O
Purity:
Min. 95%
Color and Shape:
White/Off-White Solid
Molecular weight:
256.09 g/mol
Ref: 3D-FA168205
2mg | 167.00 € | ||
5mg | 250.00 € | ||
10mg | 376.00 € | ||
25mg | 666.00 € | ||
50mg | 996.00 € |
Estimated delivery in United States, on Tuesday 26 Nov 2024